This document discusses avoiding drug residues in livestock. It notes that using penicillin purchased from a feed store according to typical doses and routes of administration would result in an illegal residue, as this would constitute extralabel use without veterinary oversight. The best option presented is to consult the drug label for the appropriate withdrawal time. The document emphasizes that extralabel drug use can only be done legally under veterinary guidance within a veterinarian-client-patient relationship.
Dr. David Goldman - Meat/Poultry Antibiotic Residue Testing, Protecting Human...John Blue
Meat/Poultry Antibiotic Residue Testing, Protecting Human Health - Dr. David Goldman, Chief Medical Officer, USPHS Office of Public Health Science, Food Safety and Inspection Service, from the 2013 NIAA Symposium Bridging the Gap Between Animal Health and Human Health, November 12-14, 2013, Kansas City, MO, USA.
More presentations at http://www.trufflemedia.com/agmedia/conference/2013-niaa-antibiotics-bridging-the-gap-animal-health-human-health
Antibiotic alternatives in veterinary therapeuticsBhoj Raj Singh
All AMR Control programs aim for improving antibiotic stewardship & finding alternative antimicrobials with an aim to reduce antibiotic use. The present presentation (delivered at the one-week Short-term Training Course organized by ICAR-IVRI Regional Station, Palampur to the field Veterinarians) summarises the possible antibiotic alternatives in veterinary therapeutics.
Causes of Emergence of Antimicrobial Drug Resistance: New Dimensions; & List ...Bhoj Raj Singh
Common Belief regarding the emergence of AMR is misuse & overuse of antibiotics in therapy and food production system. This presentation deals with the New Dimension of AMR revealing role of Producers, Distributors, Administrators and Regulators of Antibiotics in Indian perspective.
Antibiotic residues and heavy metals in pork at wet markets in VietnamILRI
Presented by Tran Thi Tuyet Hanh, Sinh Dang-Xuan, Hung Nguyen-Viet, Fred Unger, Chu Van Tuat, Ngan Tran Thi and Phuc Pham Duc at the 4th Food Safety and Zoonoses Symposium for Asia Pacific and 2nd Regional EcoHealth Symposium, Chiang Mai, Thailand, 3-5 August 2015.
Dr. David Goldman - Meat/Poultry Antibiotic Residue Testing, Protecting Human...John Blue
Meat/Poultry Antibiotic Residue Testing, Protecting Human Health - Dr. David Goldman, Chief Medical Officer, USPHS Office of Public Health Science, Food Safety and Inspection Service, from the 2013 NIAA Symposium Bridging the Gap Between Animal Health and Human Health, November 12-14, 2013, Kansas City, MO, USA.
More presentations at http://www.trufflemedia.com/agmedia/conference/2013-niaa-antibiotics-bridging-the-gap-animal-health-human-health
Antibiotic alternatives in veterinary therapeuticsBhoj Raj Singh
All AMR Control programs aim for improving antibiotic stewardship & finding alternative antimicrobials with an aim to reduce antibiotic use. The present presentation (delivered at the one-week Short-term Training Course organized by ICAR-IVRI Regional Station, Palampur to the field Veterinarians) summarises the possible antibiotic alternatives in veterinary therapeutics.
Causes of Emergence of Antimicrobial Drug Resistance: New Dimensions; & List ...Bhoj Raj Singh
Common Belief regarding the emergence of AMR is misuse & overuse of antibiotics in therapy and food production system. This presentation deals with the New Dimension of AMR revealing role of Producers, Distributors, Administrators and Regulators of Antibiotics in Indian perspective.
Antibiotic residues and heavy metals in pork at wet markets in VietnamILRI
Presented by Tran Thi Tuyet Hanh, Sinh Dang-Xuan, Hung Nguyen-Viet, Fred Unger, Chu Van Tuat, Ngan Tran Thi and Phuc Pham Duc at the 4th Food Safety and Zoonoses Symposium for Asia Pacific and 2nd Regional EcoHealth Symposium, Chiang Mai, Thailand, 3-5 August 2015.
Fast detection of Listeria monocytogenes in deli meat and dairy productsSandra Rogoza
Poster Presentation by Dr. Sergiy Olishevskyy, BSc, PhD of FoodChek Laboratories at IAFP 2016.
The ability of L. monocytogenes to proliferate in various foods at refrigeration temperatures and survive even after deep freezing makes the occurrence of this foodborne pathogen in ready-to-eat (RTE) foods of particular concern. It is especially threatening to the deli meat and dairy industries if fast and reliable detection methods are not applied. Since L. monocytogenes in RTE food can be present at low concentration with sub-lethal injury during food processing, an enrichment step is crucial to resuscitate injured cells and allow sufficient growth for detection.
The objective of this study was to validate a sensitive and rapid method for L. monocytogenes detection in deli meat and dairy products.
Ciprofloxacin resideu and their impact on Biomolecules n eggs of laying hens ...Sayed Koushik Ahamed
I have done this research on eggs for the welfare of mankind now i want to share my article for social awareness. I hope it will helps all researchers for their future further research.
Thank You
Mycotoxins are a major hazard to humans and animals, often being found in a wide range of food and feed samples and causing cancer as a result of ingestion of contaminated commodities.
Phytogenics as feed additives in poultry productionReza Vakili
1. Effects on egg production& egg quality
2.Growth promoting effect
3.Impact Influence on palatability and gut function
4. Antimicrobial action &Impact on pathogenic microorganisms
5. Antioxidant and anti-inflammatory action
6. Effect on immune system function
7. AntiCancer properties
Who is responsible for Emerging Antimicrobial Drug Resistance: Antibiotic Use...Bhoj Raj Singh
Antimicrobial resistance is an all-time serious problem and clinicians, veterinarians and livestock owners are often held responsible for its emergence and spread. In the presentation, bigger players of this dogma have been revealed.
Testing of neutraceuticals and food productsAbhishek Rana
Testing of neutraceuticals and food products includes Testing of microbial load, nutritional value, heavy
metals, calorific value and neutraceutical label claim test.
Brief introduction to Agmark, Bureau of Indian Standards (BIS) and Food Safety and Standards
Authority of India (FSSAI).
This presentation was made in Sept 2010 at Manila during the Poultry show. Target audience were nutritionists , poultry consultants and feed manufacturers
Aflatoxin M1 in milk and dairy products screening toolsTECNA Srl
Aflatoxin M1 is the product of aflatoxin B1 transformation in the digestive apparatus of dairy animals. Once these animals are fed with B1 contaminated feed, liver enzymes transform it into aflatoxin M1. This toxin is found then in milk and dairy products and, even if less toxic than its precursor, is still mutagenic and carcinogenic. Due to aflatoxin M1 toxicity and the likelihood of its presence in milk and dairy products, the level of this toxin is strictly regulated from European and International laws.
In the EU, the maximum tolerated level of aflatoxin M1 is 0.05 parts per billion (ppb), and a lower limit of 0.025 ppb is envisaged for so called baby-foods. In the US, the Food and Drug Administration (FDA) established a maximum level for aflatoxin M1 of 0.5 ppb; China –with GB 2761-2011- and the International CODEX ALIMENTARIUS adopted the same limit as well.
Tecna presents here its portfolio of products dedicated to aflatoxin M1 screening in milk and dairy products. In order to fulfill international regulations new kits for extra EU markets have been recently introduced.
Effect of Some Disinfectants on Antibiotic Resistance Staphylococcus Isolated...iosrjce
IOSR Journal of Agriculture and Veterinary Science (IOSR-JAVS) is a double blind peer reviewed International Journal edited by the International Organization of Scientific Research (IOSR). The journal provides a common forum where all aspects of Agricultural and Veterinary Sciences are presented. The journal invites original papers, review articles, technical reports and short communications containing new insight into any aspect Agricultural and Veterinary Sciences that are not published or not being considered for publication elsewhere.
In this webinar, you will learn:
Sources of endotoxin contamination
Contamination control strategy
Endotoxin removal strategies
Detailed description:
Endotoxin, a lipopolysaccharide (LPS), is a type of pyrogen and is a component of the exterior cell wall of Gram-negative bacteria. To ensure safety on patient’s endotoxin content in the drug should always be controlled. In a biological processing it may emanate from facility, utility, raw materials, process, and personnel. In this webinar we discuss the regulatory norms, strategies for prevention & removal of endotoxin to ensure that the final drug product is safe.
2019 Feed and Grain Mycotoxin Workshop PresentationPatrick Frasco
Dr. Erin Bowers, Professor at Iowa State University and Pat Frasco Director of Sales Milling & Grain for Neogen presented mycotoxin testing best practices
No animal can be bred in a sterile environment.
Invariably Antibiotics are to be used.
Since Resistance is rising and since residual antibiotics in food chain is becoming alarming several countries have banned use of Antibiotics in Animal rearing.
Hence it is high time to probe, find and use alternatives which are safe and does not cause immunity.
This article presents various alternatives that can be attempted right now.
Preventing Residues in Tissues and Milk- Craig ShultzDAIReXNET
Dr. Shultz presented this material on November 10, 2011 as part of DAIReXNET's webinar entitled "Appropriate Drug Use and Residue Avoidance Practices".
Critical Economic Decisons when Raising HeifersDAIReXNET
Jason Karszes presented this for DAIReXNET on December 16th, 2013. For more information, please see our archived webinars page at www.extension.org/pages/15830/archived-dairy-cattle-webinars.
Fast detection of Listeria monocytogenes in deli meat and dairy productsSandra Rogoza
Poster Presentation by Dr. Sergiy Olishevskyy, BSc, PhD of FoodChek Laboratories at IAFP 2016.
The ability of L. monocytogenes to proliferate in various foods at refrigeration temperatures and survive even after deep freezing makes the occurrence of this foodborne pathogen in ready-to-eat (RTE) foods of particular concern. It is especially threatening to the deli meat and dairy industries if fast and reliable detection methods are not applied. Since L. monocytogenes in RTE food can be present at low concentration with sub-lethal injury during food processing, an enrichment step is crucial to resuscitate injured cells and allow sufficient growth for detection.
The objective of this study was to validate a sensitive and rapid method for L. monocytogenes detection in deli meat and dairy products.
Ciprofloxacin resideu and their impact on Biomolecules n eggs of laying hens ...Sayed Koushik Ahamed
I have done this research on eggs for the welfare of mankind now i want to share my article for social awareness. I hope it will helps all researchers for their future further research.
Thank You
Mycotoxins are a major hazard to humans and animals, often being found in a wide range of food and feed samples and causing cancer as a result of ingestion of contaminated commodities.
Phytogenics as feed additives in poultry productionReza Vakili
1. Effects on egg production& egg quality
2.Growth promoting effect
3.Impact Influence on palatability and gut function
4. Antimicrobial action &Impact on pathogenic microorganisms
5. Antioxidant and anti-inflammatory action
6. Effect on immune system function
7. AntiCancer properties
Who is responsible for Emerging Antimicrobial Drug Resistance: Antibiotic Use...Bhoj Raj Singh
Antimicrobial resistance is an all-time serious problem and clinicians, veterinarians and livestock owners are often held responsible for its emergence and spread. In the presentation, bigger players of this dogma have been revealed.
Testing of neutraceuticals and food productsAbhishek Rana
Testing of neutraceuticals and food products includes Testing of microbial load, nutritional value, heavy
metals, calorific value and neutraceutical label claim test.
Brief introduction to Agmark, Bureau of Indian Standards (BIS) and Food Safety and Standards
Authority of India (FSSAI).
This presentation was made in Sept 2010 at Manila during the Poultry show. Target audience were nutritionists , poultry consultants and feed manufacturers
Aflatoxin M1 in milk and dairy products screening toolsTECNA Srl
Aflatoxin M1 is the product of aflatoxin B1 transformation in the digestive apparatus of dairy animals. Once these animals are fed with B1 contaminated feed, liver enzymes transform it into aflatoxin M1. This toxin is found then in milk and dairy products and, even if less toxic than its precursor, is still mutagenic and carcinogenic. Due to aflatoxin M1 toxicity and the likelihood of its presence in milk and dairy products, the level of this toxin is strictly regulated from European and International laws.
In the EU, the maximum tolerated level of aflatoxin M1 is 0.05 parts per billion (ppb), and a lower limit of 0.025 ppb is envisaged for so called baby-foods. In the US, the Food and Drug Administration (FDA) established a maximum level for aflatoxin M1 of 0.5 ppb; China –with GB 2761-2011- and the International CODEX ALIMENTARIUS adopted the same limit as well.
Tecna presents here its portfolio of products dedicated to aflatoxin M1 screening in milk and dairy products. In order to fulfill international regulations new kits for extra EU markets have been recently introduced.
Effect of Some Disinfectants on Antibiotic Resistance Staphylococcus Isolated...iosrjce
IOSR Journal of Agriculture and Veterinary Science (IOSR-JAVS) is a double blind peer reviewed International Journal edited by the International Organization of Scientific Research (IOSR). The journal provides a common forum where all aspects of Agricultural and Veterinary Sciences are presented. The journal invites original papers, review articles, technical reports and short communications containing new insight into any aspect Agricultural and Veterinary Sciences that are not published or not being considered for publication elsewhere.
In this webinar, you will learn:
Sources of endotoxin contamination
Contamination control strategy
Endotoxin removal strategies
Detailed description:
Endotoxin, a lipopolysaccharide (LPS), is a type of pyrogen and is a component of the exterior cell wall of Gram-negative bacteria. To ensure safety on patient’s endotoxin content in the drug should always be controlled. In a biological processing it may emanate from facility, utility, raw materials, process, and personnel. In this webinar we discuss the regulatory norms, strategies for prevention & removal of endotoxin to ensure that the final drug product is safe.
2019 Feed and Grain Mycotoxin Workshop PresentationPatrick Frasco
Dr. Erin Bowers, Professor at Iowa State University and Pat Frasco Director of Sales Milling & Grain for Neogen presented mycotoxin testing best practices
No animal can be bred in a sterile environment.
Invariably Antibiotics are to be used.
Since Resistance is rising and since residual antibiotics in food chain is becoming alarming several countries have banned use of Antibiotics in Animal rearing.
Hence it is high time to probe, find and use alternatives which are safe and does not cause immunity.
This article presents various alternatives that can be attempted right now.
Preventing Residues in Tissues and Milk- Craig ShultzDAIReXNET
Dr. Shultz presented this material on November 10, 2011 as part of DAIReXNET's webinar entitled "Appropriate Drug Use and Residue Avoidance Practices".
Critical Economic Decisons when Raising HeifersDAIReXNET
Jason Karszes presented this for DAIReXNET on December 16th, 2013. For more information, please see our archived webinars page at www.extension.org/pages/15830/archived-dairy-cattle-webinars.
Better Milk Quality from Better Mastitis Therapy Decisions- Dr. Ron ErskineDAIReXNET
Dr. Ron Erskine presented this information for DAIReXNET on Tuesday, February 12, 2013. For more information, please see our archived webinars page at www.extension.org/pages/15830/archived-dairy-cattle-webinars.
Far Off To Fresh Cow- Opportunities to Improve Transition PerformanceDAIReXNET
Dr. mike Overton presented this information for DAIReXENT on Monday, March 18, 2013. For more information, please see our archived webinars page at www.extension.org/pages/15830/archived-dairy-cattle-webinars.
The Importance of Good Handling Skills for Dairy CowsDAIReXNET
Dr. Proudfoot presented this information for DAIReXNET on November 5, 2015. To see the full recorded webinar, please visit http://www.extension.org/pages/15830/archived-dairy-cattle-webinars
Hyperketonemia Treatment at the Individual Cow and Herd LevelDAIReXNET
Dr. Jessica McArt presented this material for a DAIReXNET webinar on January 19, 2016. To see more about this and other webinars, please visit our archived webinar page at http://bit.ly/1wb83YV
Bovine Leukosis Virus: What is it and What Does it Mean for Me?DAIReXNET
Dr. Ray Sweeney presented this material for DAIReXNET on October 14, 2015. To view the full presentation, please see our archived webinars page at http://www.extension.org/pages/15830/archived-dairy-cattle-webinars
Basic Vaccinology: Why Vaccines Work or Don't WorkDAIReXNET
Dr. Dan Grooms presented this information for DAIReXNET on January 13th, 2014. For more information, please see our archived webinars page at www.extension.org/pages/15830/archived-dairy-cattle-webinars.
Current Options in Farm Animal Welfare Audits - Jim ReynoldsDAIReXNET
Dr Jim Reynolds presented this information on February 8th 2012 for DAIReXNET. He discussed the various options available for animal welfare certification on dairy farms, as well as what certification is and how to decide if it's right for you or your clients.
An Overview of Work Safey and Health Issues on Dairy FarmsDAIReXNET
Dr. Dennis Murphy presented this as part of a DAIReXNET educational video released in February 2017. To see the full presentation, visit https://www.youtube.com/watch?v=Ap864V2Feag
Economic Analysis Tools for Dairy Reproduction ProgramsDAIReXNET
This material was presented by Dr. Victor Cabrera for DAIReXNET on Monday, April 8, 2013. For more information, please see our archived webinars page at www.extension.org/pages/15830/archived-dairy-cattle-webinars.
Diagnosing and Monitoring Ketosis in Dairy HerdsDAIReXNET
Dr. Gary Oetzel presented this material for DAIReXNET on January 5th, 2016. To see more about this and other webinars, please visit our archived webinar page at http://bit.ly/1wb83YV
Dr. Stephen LeBlanc presented this for DAIReXNET as part of our educational video series. View the full presentation at https://www.youtube.com/watch?v=IH4vPuOTFyM
Dr. James McKean - FDA Antimicrobial UpdateJohn Blue
FDA Antimicrobial Update - James McKean, DVM, PhD, Extension Veterinarian, Iowa State University, from the 2014 NIAA Annual Conference titled 'The Precautionary Principle: How Agriculture Will Thrive', March 31 - April 2, 2014, Omaha, NE, USA.
More presentations at http://www.trufflemedia.com/agmedia/conference/2014_niaa_how_animal_agriculture_will_thrive
Dr. Patrick Gorden - Animal Medicinal Drug Use Clarification Act (AMDUCA)John Blue
Animal Medicinal Drug Use Clarification Act (AMDUCA) - Dr. Patrick Gorden, College of Veterinary Medicine, Iowa State University, from the 2017 NIAA Annual Conference, U.S. Animal Agriculture's Future Role In World Food Production - Obstacles & Opportunities, April 4 - 6, Columbus, OH, USA.
More presentations at http://www.trufflemedia.com/agmedia/conference/2017_niaa_us_animal_ag_future_role_world_food_production
Standard of antiblastic drug administration Anita Zeneli
Theoretical and practical course for oncology nurses at Bugando Medical Centre (Tanzania). This presentation is based on the standard for chemotherapy administration (ONS and ASCO 2011). The course has been tailored to the training needs of the Oncology Ward of Bugando Centre. Two our colleagues Dr Samantha Sarti (Oncologist) and Giulia Severi (Oncology Nurse) both at IRCCS IRST Meldola Italy, went at Bugando Medical Centre and worked as volunteers with Tanzanian nurses for a month. During this period they evaluated nurses training needs and reported us, so we prepared a training course with specific objectives. The difficulty was to convey to them the updated contents for use with the resources they have available.
ABSTRACT
Overactive bladder (OAB) is a prevalent condition which has an adverse effect on quality of life. The presence
of urgency incontinence confers significant morbidity above and beyond that of OAB sufferers who are
continent. The primary treatment for OAB and urgency incontinence is a combination of behavioral measures
and antimuscarinic drug therapy. The ideal antimuscarinic agent should effectively relieve the symptoms of
OAB, with the minimum of side effects; it should be available as a once-daily sustained release formulation
and in dosage strength that allows easy dose titration for the majority of sufferers. Solifenacin succinate was
launched in 2005 and has been shown in both short and long term clinical trials to fulfill these requirements.
Solifenacin is a competitive M3 receptor antagonist with a long half-life (45-68 hours). It is available in two
dosage strengths namely a 5 or 10 mg once-daily tablet. The efficacy and tolerability of solifenacin for the
treatment of all symptoms of OAB has been evaluated in a number of large, placebo controlled, randomized
trials. Long-term safety, efficacy, tolerability and persistence with treatment have been established in an open
label 40 week continuation study.
KEYWORDS
Solifenacin, Urinary incontinence, Overactive bladder and Wet granulation method.
Dr. Eliana Paladino - How the GFI#213/VFD Affected the Pattern of Submissions...John Blue
How the GFI#213/VFD Affected the Pattern of Submissions at the UMN-VDL - Dr. Eliana Paladino, from the 2017 Allen D. Leman Swine Conference, September 16-19, 2017, St. Paul, Minnesota, USA.
More presentations at http://www.swinecast.com/2017-leman-swine-conference-material
Uterine Health and Potential Connection with Genetic VariationDAIReXNET
Dr. Galvão joins us to discuss uterine diseases, their effects on fertility, and a possible genetic connection. Learn about his research methods, the detrimental effects of metritis on fertility, and which genes could be related to uterine diseases.
To view the full presentation, visit https://www.youtube.com/watch?v=jZvuFi_qKPQ
Dr. De Vries discusses how to find the value in genomic testing – and which situations it may be valuable in – as well as how some reproductive program decisions can affect profitability.
Find the full presentation on YouTube at https://www.youtube.com/watch?v=VnTovy_gUQA
Dr. Dave Van Metre presented this material on bovine foot rot and digital dermatitis for DAIReXNET. He covers some anatomy and explains why foot rot and digital dermatitis develop, as well as discussing ways to prevent and treat both conditions.
View the full presentation at www.youtube.com/watch?v=BbvV3O0vIqk
How Dairy Cattle Facilities May Contribute to LamenessDAIReXNET
Dan McFarland joins us to discuss how dairy facilities can contribute to lameness problems. Learn about resting and flooring surfaces, slip hazards, and how heat stress and heifer rearing can factor in.
You can find the full presentation at https://www.youtube.com/watch?v=HNyfdyTrZq0
This material was presented by Dr. Ernest Hovingh for DAIReXNET. See the full presentation on YouTube at https://www.youtube.com/watch?v=OS6U8EJBp7A
Learn about lameness prevention in dairy cattle with a focus on footbaths! Dr. Hovingh discusses infectious and non-infectious lameness conditions, ideal design and placement of foot baths, appropriate solutions and handling, and more tactics to help you get the most out of this prevention tool.
Nutrition affects lameness and hoof health in a variety of ways. Learn about both direct and indirect impacts of nutrition, such as acidosis and metabolic diseases, as well as how interactions between nutrition and environment can play a part.
You can find the full presentation on YouTube at https://www.youtube.com/watch?v=BlM6pfj_WZ8
Dr. Proudfoot joins us to discuss early identification of lameness in dairy cattle. Learn about how the prevalence of lameness is often underestimated, how you can improve detection, and some automated tools to aid in early detection that are currently in development.
See the full presentation on YouTube at www.youtube.com/watch?v=Ho6wh-Ns6YM
Implementing and Evaluating a Selective Dry Cow Therapy ProgramDAIReXNET
Pamela Ruegg joins us to discuss selective dry cow therapy. Learn about implementing and evaluating a program, as well as how to decide whether selective therapy might be a good fit for your operation. View the full presentation at https://www.youtube.com/watch?v=VKRAqHQZIng
New Insights Into the People Side of Milk QualityDAIReXNET
From attitudes and perspectives to the relationship between employer and employee, Susan Schexnayder discusses new insights into the roles people can play in milk quality. For the full presentation, see our YouTube video at https://www.youtube.com/watch?v=2zTS4D7KZiE
Feeding Dry Dairy Cows Lower Energy DietsDAIReXNET
Dr. Heather Dann presented this information for DAIReXNET. Learn about the importance of transition cow management, and how feeding lower-energy transition diets could benefit a herd. From monitoring intake to coordinating various diets, Dr. Dann offers insights into setting cows up for success in their next lactation. Available on YouTube at https://www.youtube.com/watch?v=ImX7bVlfdSo
Defining a Compensation Structure for the Dairy WorkforceDAIReXNET
In this presentation, Felix Soriano of APN Consulting leads us through important aspects of a compensation package, including indirect pay and tips for bonuses.
You can find the full presentation on Youtube at: https://www.youtube.com/watch?v=lKyiov1DSbk
Current Research in Genomic Selection- Dr. Joe DaltonDAIReXNET
Dr. Dalton presented this material for a DAIReXNET webinar. You can view the recorded webinar on YouTube at https://www.youtube.com/watch?v=BL1jb8WY8lk
An Overview of Genomic Selection and FertilityDAIReXNET
In this webinar, released July 18, 2016, Dr. Hansen joined us to discuss genomic selection as it relates to fertility traits. Learn about single nucleotide polymorphisms (SNPs), the challenges in selecting for reproductive traits, and some of the current work in overcoming those challenges.
This information was presented for DAIReXNET and released as a webinar on June 20th, 2016. In this webinar, Dr. Nickerson discusses the prevalence and treatment of mastitis in bred heifers, as well as several strategies for prevention. Learn about using teat seals, controlling horn fly populations, vaccinations, and feed additives that might help reduce the incidence of new infections.
Dr. Milo Wiltbank presented this for a DAIReXNET webinar on Wednesday, March 2, 2016. The full presentation recording can be found at http://bit.ly/1wb83YV.
Sire Selection Considerations for Dairy ProducersDAIReXNET
Dr. Chad Dechow presented this material for a DAIReXNET webinar on February 1, 2016. To see the full recorded webinar, please visit our archive at http://bit.ly/1wb83YV
This presentation includes basic of PCOS their pathology and treatment and also Ayurveda correlation of PCOS and Ayurvedic line of treatment mentioned in classics.
2024.06.01 Introducing a competency framework for languag learning materials ...Sandy Millin
http://sandymillin.wordpress.com/iateflwebinar2024
Published classroom materials form the basis of syllabuses, drive teacher professional development, and have a potentially huge influence on learners, teachers and education systems. All teachers also create their own materials, whether a few sentences on a blackboard, a highly-structured fully-realised online course, or anything in between. Despite this, the knowledge and skills needed to create effective language learning materials are rarely part of teacher training, and are mostly learnt by trial and error.
Knowledge and skills frameworks, generally called competency frameworks, for ELT teachers, trainers and managers have existed for a few years now. However, until I created one for my MA dissertation, there wasn’t one drawing together what we need to know and do to be able to effectively produce language learning materials.
This webinar will introduce you to my framework, highlighting the key competencies I identified from my research. It will also show how anybody involved in language teaching (any language, not just English!), teacher training, managing schools or developing language learning materials can benefit from using the framework.
Executive Directors Chat Leveraging AI for Diversity, Equity, and InclusionTechSoup
Let’s explore the intersection of technology and equity in the final session of our DEI series. Discover how AI tools, like ChatGPT, can be used to support and enhance your nonprofit's DEI initiatives. Participants will gain insights into practical AI applications and get tips for leveraging technology to advance their DEI goals.
How to Build a Module in Odoo 17 Using the Scaffold MethodCeline George
Odoo provides an option for creating a module by using a single line command. By using this command the user can make a whole structure of a module. It is very easy for a beginner to make a module. There is no need to make each file manually. This slide will show how to create a module using the scaffold method.
Normal Labour/ Stages of Labour/ Mechanism of LabourWasim Ak
Normal labor is also termed spontaneous labor, defined as the natural physiological process through which the fetus, placenta, and membranes are expelled from the uterus through the birth canal at term (37 to 42 weeks
A Strategic Approach: GenAI in EducationPeter Windle
Artificial Intelligence (AI) technologies such as Generative AI, Image Generators and Large Language Models have had a dramatic impact on teaching, learning and assessment over the past 18 months. The most immediate threat AI posed was to Academic Integrity with Higher Education Institutes (HEIs) focusing their efforts on combating the use of GenAI in assessment. Guidelines were developed for staff and students, policies put in place too. Innovative educators have forged paths in the use of Generative AI for teaching, learning and assessments leading to pockets of transformation springing up across HEIs, often with little or no top-down guidance, support or direction.
This Gasta posits a strategic approach to integrating AI into HEIs to prepare staff, students and the curriculum for an evolving world and workplace. We will highlight the advantages of working with these technologies beyond the realm of teaching, learning and assessment by considering prompt engineering skills, industry impact, curriculum changes, and the need for staff upskilling. In contrast, not engaging strategically with Generative AI poses risks, including falling behind peers, missed opportunities and failing to ensure our graduates remain employable. The rapid evolution of AI technologies necessitates a proactive and strategic approach if we are to remain relevant.
it describes the bony anatomy including the femoral head , acetabulum, labrum . also discusses the capsule , ligaments . muscle that act on the hip joint and the range of motion are outlined. factors affecting hip joint stability and weight transmission through the joint are summarized.
A review of the growth of the Israel Genealogy Research Association Database Collection for the last 12 months. Our collection is now passed the 3 million mark and still growing. See which archives have contributed the most. See the different types of records we have, and which years have had records added. You can also see what we have for the future.
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...Dr. Vinod Kumar Kanvaria
Exploiting Artificial Intelligence for Empowering Researchers and Faculty,
International FDP on Fundamentals of Research in Social Sciences
at Integral University, Lucknow, 06.06.2024
By Dr. Vinod Kumar Kanvaria
A workshop hosted by the South African Journal of Science aimed at postgraduate students and early career researchers with little or no experience in writing and publishing journal articles.
Thinking of getting a dog? Be aware that breeds like Pit Bulls, Rottweilers, and German Shepherds can be loyal and dangerous. Proper training and socialization are crucial to preventing aggressive behaviors. Ensure safety by understanding their needs and always supervising interactions. Stay safe, and enjoy your furry friends!
Residues and How to Avoid Them: It's Black and White- Mike Apley
1. Residues and How to Avoid Them:
It’s Black and White
Mike Apley, DVM, PhD
2. Extralabel Penicillin Use
You purchase procaine Pen G from the feedstore and use it
according to your typical dose of 5 cc/100 lbs under the
skin. To avoid a residue, which of the following would be your
best option.
1.) Consult the label for the appropriate withdrawal time
2.) I would stop because as described above this is an illegal act unless a
veterinarian is involved
3.) This would be fine if I injected the drug intramuscularly because the
subcutaneous (under the skin) route would be off label
4.) I should only purchase this from a route truck because they will be
able to help me with the proper procedure that others are using
3. Residues: It’s Black and White
• Residues occur when detected concentrations
of the marker residue are above the approved
tolerance for that drug in that tissue.
• Residues are monitored in target tissues; the
tissues which hold the residue the longest.
These tissues indicate the status of other
edible tissues in the animal.
4. So…….
• There can be legally acceptable concentrations
of drugs in edible tissues (except for a
carcinogenic parent drug or metabolites) at
slaughter IF there is an established tolerance
in tissues for that animal species.
• For drugs without a label and corresponding
tolerance in a species (including use class and
edible tissue), then any residue detected is
violative.
9. 9
An Interactive Database Containing
Information Acquired During FDA/State
Inspections of Firms Involved/Responsible
for Tissue Residue Violations.
Attachment C Ensures Consistent Data
Collection by both Federal and State
Investigators.
Attachment C Forms are Entered into
TRIMS
Slide courtesy of Drs. Deborah Cera and
Randy Arbaugh, FDA/CVM
10. 10
Treatment Records Drugs Given or
Not Maintained Fed by Mistake
Withdrawal Time
Not Followed
Exceeded
Approved Dose
Extra Label Use by
Laymen
Slide courtesy of Drs. Deborah Cera and Randy Arbaugh, FDA/CVM
11. Reason Drug Used - FY08
Preventive
12%
Illness
88%
Slide courtesy of Drs. Deborah Cera and Randy Arbaugh, FDA/CVM
11/10/2011
11
12. Yes
30%
No
70%
Slide courtesy of Drs. Deborah Cera and Randy Arbaugh, FDA/CVM
11/10/2011
12
13. Withdrawal times must be extended
in the case of extralabel use
But, under absolutely no
circumstances is there justification
for shortening a withdrawal period
14. Things that get us in trouble…
• Just blowing off withdrawal times
• No records
• No protocols
• No training of employees on protocols
• Extra-label use (ELDU) without the proper
guidance
– Under the AMDUCA regulations, a veterinarian
MUST be involved in any ELDU in the form of a
VCPR
15. Extralabel use (ELDU)
• Whenever a drug is used other than exactly as
specified on the label
– Dose
– Route
– Duration
– Frequency
– Injection site (location and volume per site)
– Treatment indication
– Animal species and use class
16. Animal Medicinal Drug Use
Clarification Act (AMDUCA)
• The regulations written for this act are what
we really need to understand.
• There is a clear hierarchy of uses in the
AMDUCA regulations
– Use of a labeled product as labeled
– Use of a food animal-labeled product in an
extralabel manner
– Use of a human or non-food animal veterinary
labeled drug
– Use of a compounded drug
17. AMDUCA
• Applies only within the confines of a valid
veterinary-client-patient relationship
• The regulations apply only to products that
are approved for use in either animals or
humans
– For example, solvent grade DMSO is not legal to
put in a food animal at any time. The animal
would be adulterated by using this product.
18. The vets job in ELDU
• Confirm it is legal
• Determine that the use makes sense medically
• Determine the extended withdrawal time
– There must be information available to do this or the
drug cannot be used in this manner
• Assure that the animals are correctly identified for
observation of the extended withdrawal time
• Provide the drug or the prescription
19. Practices that just don’t make sense
• Putting an entire dose of Penicillin G in one
spot
– And what about procaine/benzathine pen G?
• Putting a drug in another injection site than as
labeled
– Moving ceftiofur crystalline free acid to the neck
instead of the ear or base of the ear
– Giving flunixin meglumine intramuscularly
20. Practices that just don’t make sense
• Gentamicin
– There IS a reason why FARAD recommends an 18
month slaughter withdrawal time for this drug.
– It lights up prolonged kidney residues even when
given intramammary
• Using any drug in an extralabel manner
outside the presence of a veterinary-client-
patient relationship (this would be illegal)
21. Practices that just don’t make sense
• Using compounded products outside of
compliance with the AMDUCA regulations
– There is a compliance policy guideline for
compounding. (CPG 608.400)
– The FDA/CVM DOES have the authority to regulate
compounded products just as they do for
approved drugs.
22. CPG 608.400 Excerpts
• “However, FDA is greatly concerned about veterinarians
and pharmacies that are engaged in manufacturing and
distributing unapproved new animal drugs in a manner
that is clearly outside the bounds of traditional pharmacy
practice and that violates the Act (e.g., compounding that
is intended to circumvent the drug approval process and
provide for the mass marketing of products that have been
produced with little or no quality control or manufacturing
standards to ensure the purity, potency, and stability of the
product).”
23. CPG 608.400 Excerpts
• “These activities are the focus of this
guidance. Pharmacies and veterinarians who
engage in activities analogous to
manufacturing and distributing drugs for use
in animals may be held to the same provisions
of the Act as manufacturers.”
24. CPG 608.400 Excerpts
• “With regard to compounding from bulk drug substances,
two Federal Appeals Court decisions, United States v.
Algon Chemical Inc., 879 F.2d 1154 (3d Cir. 1989) and
United States v. 9/1 Kg. Containers, 854 F.2d 173 (7th Cir.
1988), affirmed the FDA position that the Act does not
permit veterinarians to compound unapproved finished
drug products from bulk drug substances, unless the
finished drug is not a new animal drug. The principle
established by the court applies equally to compounding
by pharmacists.”
25. CPG 608.400 Excerpts
• “Neither the Act nor its implementing regulations exempt veterinarians
or pharmacists from the approval requirements in the new animal drug
provisions of the Act, 21 U.S.C. Section 360b. In the absence of an
approved new animal drug application, the compounding of a new
animal drug from any unapproved drug or from bulk drug substances
results in an adulterated new animal drug in violation of section 21
U.S.C. Section 351(a)(5). The compounding of a new animal drug from
an approved human or animal drug also results in an adulterated new
animal drug in violation of 21 U.S.C. Section 351(a)(5), unless the
conditions set forth in 21 CFR 530.13(b) are met.”
26. It all comes down to…
• Develop a treatment protocol
– Case definition
– Regimen (with a qualified veterinarian)
– Outcome definitions
– Animal disposition (animal ID!)
• Adhere to the protocol
• Monitor adherence and outcomes
– Records (and check them before selling an animal)